STOCK TITAN

iRhythm Holdings (IRTC) Stock News, Feb-Jun 2024

IRTC Nasdaq

iRhythm Holdings, Inc. reports developments for a digital health care business focused on ambulatory cardiac monitoring and arrhythmia detection. The company’s recurring updates center on the Zio ambulatory ECG portfolio, which combines patch-based monitoring, AI-powered analysis, and clinical data review to deliver cardiac rhythm insights to physicians.

Company news commonly covers quarterly and annual financial results, revenue guidance, margin trends, and operating leverage, along with clinical evidence presented at cardiology meetings. Other updates include clinician education initiatives, investor conference participation, board and governance changes, and the company’s completed transition to a holding-company structure as successor registrant to iRhythm Technologies.

Rhea-AI Summary

iRhythm Technologies (NASDAQ: IRTC), a leader in digital healthcare, announced its participation in the 2024 Truist Securities MedTech Conference. The company will engage in a fireside chat on June 18 at 9:20 a.m. ET. Stakeholders can access the live and archived webcast on iRhythm's investor website, providing insights into the company's strategies and innovations in disease detection and prevention.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.26%
Tags
conferences
-
Rhea-AI Summary

iRhythm Technologies (NASDAQ: IRTC), a leading digital healthcare provider, will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for June 5, 2024, at 11:20 a.m. Central Time. Attendees can access the live and archived webcast via the company's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.81%
Tags
conferences
-
Rhea-AI Summary

iRhythm Technologies, a digital healthcare company, reported first quarter 2024 financial results with revenue of $131.9 million, an 18.4% increase from last year. Gross margin was 66.3% with cash reserves of $569.1 million. They increased their fiscal year 2024 revenue guidance to $578-$588 million. Operational highlights included over half a million registrations and collaborations to drive efficiencies. The CEO highlighted strong revenue growth, increased traction in primary care, and the potential of EKG data for clinical insights.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.4%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.92%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.69%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.26%
Tags
conferences earnings

FAQ

What is the current stock price of iRhythm Holdings (IRTC)?

The current stock price of iRhythm Holdings (IRTC) is $113.66 as of September 30, 2026.

What is the market cap of iRhythm Holdings (IRTC)?

The market cap of iRhythm Holdings (IRTC) is approximately 3.7B.